Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
about
Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trialMagnetic Resonance Biomarkers in Neonatal Encephalopathy (MARBLE): a prospective multicountry study.Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?Lessons learned during implementation of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy in a regional transport program in Ontario.Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain.
P2860
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@ast
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@en
type
label
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@ast
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@en
prefLabel
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@ast
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@en
P2860
P356
P1476
Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy.
@en
P2093
P2860
P304
P356
10.1136/ADC.2004.057059
P577
2005-05-01T00:00:00Z